Boston Scientific's $3.7B Axonics merger delayed to H2 2024 due to US FTC's second info request.
Boston Scientific's planned $3.7B merger with Axonics is now expected in H2 2024 due to a second request for additional info from the US FTC. The second request extends the waiting period under the HSR Act until 30 days after both companies comply, unless extended or terminated earlier. The deal, initially expected in H1 2024, remains subject to the HSR Act waiting period and other closing conditions.
April 04, 2024
6 Articles